rethinkPeptides Search
Menu
Research citation

An HIV-1 gp41 peptide-liposome vaccine elicits neutralizing epitope-targeted antibody responses in healthy individuals.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

An HIV-1 gp41 peptide-liposome vaccine elicits neutralizing epitope-targeted antibody responses in healthy individuals.

medRxiv : the preprint server for health sciences

Citation

Erdmann, Nathaniel; Williams, Wilton B; Walsh, Stephen R; Cain, Derek W; Clark, Matthew; Tuck, Ryan; Holmes, Sommer; Clardy, Benae; Foulger, Andrew; Parks, Robert; Barr, Margaret; Eaton, Amanda; Saunders, Kevin O; Grunenberg, Nicole; Edlefsen, Paul; Goepfert, Paul A; Cohen, Kristen W; Maenza, Janine; Mayer, Kenneth; Van Tieu, Hong; Sobieszczyk, Magdalena E; Swann, Edith; Lu, Huiyin; De Rosa, Stephen C; Sagawa, Zachary K; Lin, Bob C; Carrol, Robin E; McKee, Krisha; Doria-Rose, Nicole A; Louder, Mark K; Moody, M Anthony; Fox, Christopher B; Ferrari, Guido; Edwards, Robert J; Acharya, Priyamvada; Alam, S Munir; Tomaras, Georgia D; Montefiori, David C; Gilbert, Peter B; McElrath, M Juliana; Corey, Lawrence; Haynes, Barton F; Baden, Lindsey R. (2025). An HIV-1 gp41 peptide-liposome vaccine elicits neutralizing epitope-targeted antibody responses in healthy individuals.. medRxiv : the preprint server for health sciences. https://doi.org/10.1101/2024.03.15.24304305